Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated review finds. This is a shift from the previous version of the review, which did not find sufficient ...
May 14, 2026
0
6
The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due to a loss of traditional ...
May 14, 2026
0
5
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and ...
May 12, 2026
0
6
Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate ...
May 12, 2026
0
11
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
May 11, 2026
0
9
Surgery is a complicated endeavor. Even a successful surgery can lead to complications, and even the best surgeons sometimes have unsuccessful surgeries. A surgeon must rely on visual cues and their own experience to avoid ...
May 11, 2026
0
3
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active surveillance. Use of the test to determine the need for repeat "monitoring" biopsies would have avoided up ...
May 8, 2026
0
19
More and more patients, instead of going straight to a doctor, first consult a chatbot about their symptoms. Artificial intelligence responds quickly, clearly, and without queues. But are its answers safe for patients?
May 6, 2026
0
3
Researchers at City of Hope and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC). ...
May 5, 2026
0
3
More than 400 million people experience a urinary tract infection every year, and some epidemiological studies estimate that more than half of all women will develop at least one in their lifetime. Most UTIs are caused by ...
May 4, 2026
0
27
